🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multicenter phase II trial designed to evaluate the ...
Status
Terminated
Location
Ospedale SS Antonio, Biagio e Cesare Arrigo
Start Date
2005-09
Trial ID
NCT00803530
Treatments Being Tested
This is a phase I dose escalation study to estimate the maximum tolerated d...
Status
Terminated
Location
Duke University Medical Center
Start Date
2008-07
Trial ID
NCT00590603
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide and dexamet...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2005-05
Trial ID
NCT00258245
Treatments Being Tested
This will be an open-label, non-randomized trial pilot phase II trial open ...
Status
Completed
Location
Duke University Medical Center
Start Date
2007-11
Trial ID
NCT00621023
Treatments Being Tested
This clinical research study is for patients with acute myelogenous leukemi...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
2002-04
Trial ID
NCT00184054
Treatments Being Tested
The goal of this study is to assess the short (acutte) effect of B-Turmacti...
Status
Completed
Location
Technological Center of Nutrition and Health (CTNS)
Start Date
2017-09-19
Trial ID
NCT03202901
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide and dexamet...
Status
Completed
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2005-10
Trial ID
NCT00274820
Treatments Being Tested
Primary Objectives: 1. To evaluate the toxicity and safety of a combinatio...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00469209
Treatments Being Tested
This is an open-label, phase 2 study of oral arsenic trioxide (Arsenol ®) i...
Status
Recruiting
Location
Queen Mary Hospital, Hong Kong
Start Date
2025-02-07
Trial ID
NCT06778187
Treatments Being Tested